Načítá se...
Emerging Molecular Targets for the Treatment of Refractory Sarcoidosis
Sarcoidosis is a multisystem granulomatous disease of unknown origin that has variable clinical course and can affect nearly any organ. It has a chronic course in about 25% of patients. Corticosteroids (CS) are the cornerstone of therapy but their long-term use is associated with cumulative toxicity...
Uloženo v:
| Vydáno v: | Front Med (Lausanne) |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7732552/ https://ncbi.nlm.nih.gov/pubmed/33330556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2020.594133 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|